Branding FDA Approval Generic Pharmaceutical Medicine 
The Pharma Data
MARCH 15, 2022
Agency Supports Development of Complex Generic Drug-Device Combination Product to Improve Competition and Access to More Affordable Medicines. director of the Office of Generic Drugs in the FDA Center for Drug Evaluation and Research. Today, the U.S.
XTalks
JUNE 8, 2022
In a press release , the company says the goal of the Act4Biosimilars campaign is to help “address global health inequity and inequality” by increasing access to advanced medicines like biosimilars. This will be made achievable by improving the approvability, accessibility, acceptability and affordability (the 4 A’s) of biosimilars.
Expert insights. Personalized for you.
52 
Let's personalize your content